|
|
Volumn 13, Issue 1, 2002, Pages 135-139
|
|
Allogeneic hematopoetic stem-cell transplantation for patients with relapsed or refractory lymphomas: Comparison of high-dose conventional conditioning versus fludarabine-based reduced-intensity regimens
|
|
Author keywords
Allogeneic HSCT; Hodgkin's disease; MUD transplantation; Non Hodgkin's lymphoma
|
|
Indexed keywords
ALKYLATING AGENT;
BUSULFAN;
CARMUSTINE;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN A;
ETOPOSIDE;
FLUDARABINE;
LYMPHOCYTE ANTIBODY;
MELPHALAN;
METHOTREXATE;
PREDNISONE;
THIOTEPA;
ADULT;
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION;
ARTICLE;
AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION;
B CELL LYMPHOMA;
CANCER GROWTH;
CANCER MORTALITY;
CANCER PATIENT;
CANCER RECURRENCE;
CANCER REGRESSION;
CANCER RISK;
CANCER SURVIVAL;
CHRONIC LYMPHATIC LEUKEMIA;
CLINICAL ARTICLE;
CONFIDENCE INTERVAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG MEGADOSE;
DRUG RESPONSE;
FOLLICULAR LYMPHOMA;
FOLLOW UP;
GRAFT VERSUS HOST REACTION;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HLA MATCHING;
HODGKIN DISEASE;
HUMAN;
IMMUNOCYTOMA;
LIVING DONOR;
LYMPHOBLASTOMA;
MANTLE CELL LYMPHOMA;
NONHODGKIN LYMPHOMA;
PRIORITY JOURNAL;
STEM CELL TRANSPLANTATION;
T CELL LYMPHOMA;
WHOLE BODY RADIATION;
ADULT;
DRUG RESISTANCE, NEOPLASM;
GRAFT VS HOST DISEASE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
LYMPHOMA;
MIDDLE AGED;
RECURRENCE;
SURVIVAL RATE;
TIME FACTORS;
TRANSPLANTATION, HOMOLOGOUS;
TREATMENT OUTCOME;
VIDARABINE;
|
|
EID: 0036225351
PISSN: 09237534
EISSN: None
Source Type: Journal
DOI: 10.1093/annonc/mdf010 Document Type: Article |
|
Times cited : (47)
|
|
References (13)
|
